Entering text into the input field will update the search result below

CAPS Capstone Therapeutics Corp.
Stock Price & Overview

$7.500.00 (0.00%)2:38 PM 09/28/23
OTCQB | $USD | Market Close

Charts

FFO (FWD)
PE
Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Company Profile

Capstone Therapeutics Corp. logo
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Employees
-
Founded
1987
Address
  • 1275 West Washington Street
  • Suite 104
  • Tempe, AZ, 85281
  • United States
Phone Number
602-286-5520
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.